NEW YORK (Reuters Health) – Insulin resistance shows no significant association with an increased risk of atrial fibrillation, researchers report in an October 14th on-line paper in the…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
NEW YORK (Reuters Health) – Patients undergoing hemodialysis with a dialyzer that’s sterilized by electron beam have an increased risk of thrombocytopenia, a Canadian study has shown.“Because we…
NEW YORK (Reuters Health) – Insulin sensitizers may reduce the accelerated loss in muscle mass and strength seen in elderly men with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – Lifestyle changes and treatment with metformin may offset the development of the metabolic syndrome related to androgen deprivation therapy in men with prostate…
Mike Golic, Former NFL player and host of ESPN’s Mike and Mike in the Morning, discusses the living with diabetes and the importance of changing your lifestyle to…
Mike Golic, Former NFL player and host of ESPN’s Mike and Mike in the Morning, discusses the importance of learning more about diabetes, changing your lifestyle and talking…
NEW YORK (Reuters Health) – Patients with diabetes achieve faster control of A1C, blood pressure and cholesterol targets when they see or have contact with their primary care…
NEW YORK (Reuters Health) – Random blood glucose (RBG) measurements early in pregnancy can identify women with overt diabetes in pregnancy (ODIP), researchers from UK report in the…
NEW YORK (Reuters Health) – A Danish study indicates that among patients undergoing percutaneous coronary intervention, the use of zotarolimus-eluting stents (ZESs) rather than sirolimus-eluting stents (SESs) is…